COMMUNIQUÉS West-GlobeNewswire

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
25/04/2024
- Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company [...]
Y-mAbs to Present at 2024 ASCO Annual Meeting
25/04/2024
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
25/04/2024
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, [...]
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
25/04/2024
REDWOOD CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular [...]
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study
25/04/2024
Data demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does not require ritonavir boosting SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE [...]
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
25/04/2024
In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also secreting immunoregulatory cytokines and identifying and eliminating autoreactive T cells [...]
Longeveron to Present at the Planet MicroCap Showcase
25/04/2024
MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap [...]
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
25/04/2024
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA ® CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. ( [...]
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
25/04/2024
Year-over-year revenue grows 7% , operating profit up 25% , non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at [...]
Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List
25/04/2024
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek’s list of The World’s Best Digital Health Companies [...]
Teladoc Health Reports First Quarter 2024 Results
25/04/2024
PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 (“First [...]
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
25/04/2024
SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare [...]
Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering
25/04/2024
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
25/04/2024
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying common stock warrants to [...]
Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
25/04/2024
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period [...]
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles
25/04/2024
– Company creating de novo designed macrocycles with enhanced efficacy that precisely target disease biology – Vilya’s privileged macrocycles have the potential to be applied across broad therapeutic areas, addressing [...]
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners
25/04/2024
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS’ first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major [...]
CARBIOS pose la première pierre de son usine de biorecyclage du PET, une première mondiale, avec ses partenaires
25/04/2024
CARBIOS pose la première pierre de son usine de biorecyclage du PET, une première mondiale, avec ses partenaires Cette première usine de CARBIOS est aussi une première mondiale utilisant la technologie révolutionnaire [...]
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
25/04/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today [...]

Pages